Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration

Abstract Background The purpose of this study is to investigate the 3-year outcomes of intravitreal brolucizumab and determine the factors that affect the visual acuity (VA) in patients with neovascular age-related macular degeneration. Methods All received three consecutive, monthly, induction brol...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yume Kobayashi, Maiko Maruyama-Inoue, Tatsuya Inoue, Yasuo Yanagi, Kazuaki Kadonosono
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-04-01
סדרה:	BMC Ophthalmology
נושאים:	Age-related macular degeneration Polypoidal choroidal vasculopathy Anti-vascular endothelial growth factor Brolucizumab Subretinal fluid
גישה מקוונת:	https://doi.org/10.1186/s12886-025-04049-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!